Search research articles
Contact Us
Filters
Showing results (661-670 of 690) with videos related to
Page
of 69
Sort By:
Gastroenterology
|
August 26, 2018
Loss of MYO5B Leads to Reductions in Na<sup>+</sup> Absorption With Maintenance of CFTR-Dependent Cl<sup>-</sup> Secretion in Enterocytes
Amy C Engevik, Izumi Kaji, Melinda A Engevik, et al.
Elife
|
August 21, 2023
The negative adipogenesis regulator <i>Dlk1</i> is transcriptionally regulated by <i>Ifrd1</i> (TIS7) and translationally by its orthologue <i>Ifrd2</i> (SKMc15)
Ilja Vietor, Domagoj Cikes, Kati Piironen, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 13, 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Jill A Ohar, Gary T Ferguson, Donald A Mahler, et al.
Plos One
|
December 29, 2015
Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients
Masa-aki Higuchi, Dan D Topiol, Bilal Ahmed, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor
Robert S Eisinger, Joshua Wong, Leonardo Almeida, et al.
Human Mutation
|
February 10, 2017
Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications
Andreas R Janecke, Ruijuan Xu, Elisabeth Steichen-Gersdorf, et al.
FEBS Letters
|
August 20, 2019
LAMTOR/Ragulator regulates lipid metabolism in macrophages and foam cell differentiation
Giorgia Lamberti, Cedric H De Smet, Mihaela Angelova, et al.
Pharmacogenetics and Genomics
|
December 8, 2016
Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study
Mark W Hess, Jeroen H F de Baaij, Mark M T J Broekman, et al.
Frontiers in Molecular Neuroscience
|
March 16, 2018
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.
Pain Reports
|
July 8, 2026
Development of a core outcome set for clinical trials of extended reality for pain
Giulia Mesaroli, Courtney W Hess, Fahad Alam, et al.
Page
of 69
Search research articles
Search
Showing results (661-670 of 690) with videos related to
Sort By:
Page
of 69
Gastroenterology
|
August 26, 2018
Loss of MYO5B Leads to Reductions in Na<sup>+</sup> Absorption With Maintenance of CFTR-Dependent Cl<sup>-</sup> Secretion in Enterocytes
Amy C Engevik, Izumi Kaji, Melinda A Engevik, et al.
Elife
|
August 21, 2023
The negative adipogenesis regulator <i>Dlk1</i> is transcriptionally regulated by <i>Ifrd1</i> (TIS7) and translationally by its orthologue <i>Ifrd2</i> (SKMc15)
Ilja Vietor, Domagoj Cikes, Kati Piironen, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 13, 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Jill A Ohar, Gary T Ferguson, Donald A Mahler, et al.
Plos One
|
December 29, 2015
Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients
Masa-aki Higuchi, Dan D Topiol, Bilal Ahmed, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor
Robert S Eisinger, Joshua Wong, Leonardo Almeida, et al.
Human Mutation
|
February 10, 2017
Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications
Andreas R Janecke, Ruijuan Xu, Elisabeth Steichen-Gersdorf, et al.
FEBS Letters
|
August 20, 2019
LAMTOR/Ragulator regulates lipid metabolism in macrophages and foam cell differentiation
Giorgia Lamberti, Cedric H De Smet, Mihaela Angelova, et al.
Pharmacogenetics and Genomics
|
December 8, 2016
Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study
Mark W Hess, Jeroen H F de Baaij, Mark M T J Broekman, et al.
Frontiers in Molecular Neuroscience
|
March 16, 2018
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
Maria Perez Carrion, Francesca Pischedda, Alice Biosa, et al.
Pain Reports
|
July 8, 2026
Development of a core outcome set for clinical trials of extended reality for pain
Giulia Mesaroli, Courtney W Hess, Fahad Alam, et al.
Page
of 69